Address
9713 Key West Avenue
Rockville, MD 20850
United States of America (the)
Phone
301 944 1700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
114
First IPO Date
July 30, 2021
| Name | Title | Pay | Year Born |
| Maher Masoud | President, Chief Executive Officer & Executive Director | 919,082 | 1976 |
| Parmeet Ahuja | Chief Financial Officer | 700,557 | 1969 |
| Ana-Paula Martins Fernandes | Senior Vice President of Global Sales | 0 | N/A |
| Jill Mayer | Senior Vice President of Human Resources | 0 | N/A |
| Jay Gelfman | Chief Operations Officer | 0 | N/A |
| Jack Horgan | Senior Vice President of Corporate Development | 0 | N/A |
MaxCyte, Inc. is a global life sciences enterprise focused on the innovation, advancement, and commercialization of next-generation cell therapies. The company offers a suite of advanced electroporation systems, including the ExPERT ATx, a static device for small to medium-scale cell transfection; the ExPERT STx, which uses flow electroporation to support protein production, drug development, and the expression of therapeutic targets for cell-based assays; the ExPERT GTx, another flow electroporation solution designed for large-scale transfection in therapeutic applications; and the ExPERT VLx, catering to very high-volume cell engineering needs. Additionally, MaxCyte provides disposable processing assemblies (PAs) crucial for cell processing and electroporation, alongside essential accessories such as electroporation buffer solutions and specialized software protocols. The company, established in 1998, operates from its headquarters in Rockville, Maryland.